A recent study suggests that genotyping, a technique for analysing genetic differences, can detect new variants of SARS-CoV-2 almost a week faster than traditional methods.
Although the overall response rate among the cohort was 96.4%, this figure dropped as low as 66.7% when accounting for male gender, GT3 infection, cirrhosis, obesity, and non-response to previous therapy.